The CD4/CD8 ratio is widely used as a clinical marker of disease progression during HIV infection since it is associated with clinical outcome, immune dysfunction, and viral reservoir size in the ARV-treated individuals (41, 47). This evidence concerns the gene CD8A and HIV infectious disease.